Human leukocyte antigen selected allogeneic mesenchymal stromal cell therapy in renal transplantation: The Neptune study, a phase I single‐center study

Mesenchymal stromal cells (MSC) hold promise as a novel immune‐modulatory therapy in organ transplantation. First clinical studies have used autologous MSCs; however, the use of allogeneic "off‐the‐shelf" MSCs is more sustainable for broad clinical implementation, although with the risk of...

Descripción completa

Detalles Bibliográficos
Autores principales: Dreyer, Geertje J., Groeneweg, Koen E., Heidt, Sebastiaan, Roelen, Dave L., van Pel, Melissa, Roelofs, Helene, Huurman, Volkert A. L., Bajema, Ingeborg M., Moes, Dirk Jan A. R., Fibbe, Willem E., Claas, Frans H. J., van Kooten, Cees, Rabelink, Rabelink J., de Fijter, Johan W., Reinders, Marlies E. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Brief Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586810/
https://www.ncbi.nlm.nih.gov/pubmed/32277568
http://dx.doi.org/10.1111/ajt.15910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7586810/
https://www.ncbi.nlm.nih.gov/pubmed/32277568
http://dx.doi.org/10.1111/ajt.15910

Ejemplares similares